Network Pharmacology Reveals Polyphyllin II as One Hit of Nano Chinese Medicine Monomers against Nasopharyngeal Carcinoma

Nasopharyngeal carcinoma (NPC) is a malignant tumor in southern China, and nano Traditional Chinese Medicine (TCM) represents great potential to cancer therapy. To predict the potential targets and mechanism of polyphyllin II against NPC and explore its possibility for the future nano-pharmaceutics...

Full description

Saved in:
Bibliographic Details
Main Authors: Meng-Zhe Yang, Bei-Bei Zhang, Jian-Chun Huang, Xian-Yu Bai, Zhen-Qiang Liang, Xiang Yi, Ning Xu, Yuan-Jiao Huang, Ai-Jun Jiao
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Bioinorganic Chemistry and Applications
Online Access:http://dx.doi.org/10.1155/2021/9959634
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561135986933760
author Meng-Zhe Yang
Bei-Bei Zhang
Jian-Chun Huang
Xian-Yu Bai
Zhen-Qiang Liang
Xiang Yi
Ning Xu
Yuan-Jiao Huang
Ai-Jun Jiao
author_facet Meng-Zhe Yang
Bei-Bei Zhang
Jian-Chun Huang
Xian-Yu Bai
Zhen-Qiang Liang
Xiang Yi
Ning Xu
Yuan-Jiao Huang
Ai-Jun Jiao
author_sort Meng-Zhe Yang
collection DOAJ
description Nasopharyngeal carcinoma (NPC) is a malignant tumor in southern China, and nano Traditional Chinese Medicine (TCM) represents great potential to cancer therapy. To predict the potential targets and mechanism of polyphyllin II against NPC and explore its possibility for the future nano-pharmaceutics of Chinese medicine monomers, network pharmacology was included in the present study. Totally, ninety-four common potential targets for NPC and polyphyllin II were discovered. Gene Ontology (GO) function enrichment analysis showed that biological processes and functions mainly concentrated on apoptotic process, protein phosphorylation, cytosol, protein binding, and ATP binding. In addition, the anti-NPC effects of polyphyllin II mainly involved in the pathways related to cancer, especially in the PI3K-Akt signaling indicated by the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. The “drug-target-disease” network diagram indicated that the key genes were SRC, MAPK1, MAPK14, and AKT1. Taken together, this study revealed the potential drug targets and underlying mechanisms of polyphyllin II against NPC through modern network pharmacology, which provided a certain theoretical basis for the future nano TCM research.
format Article
id doaj-art-2dae1d28f00c4a0e99e629c6fd849d9e
institution Kabale University
issn 1565-3633
1687-479X
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series Bioinorganic Chemistry and Applications
spelling doaj-art-2dae1d28f00c4a0e99e629c6fd849d9e2025-02-03T01:25:45ZengWileyBioinorganic Chemistry and Applications1565-36331687-479X2021-01-01202110.1155/2021/99596349959634Network Pharmacology Reveals Polyphyllin II as One Hit of Nano Chinese Medicine Monomers against Nasopharyngeal CarcinomaMeng-Zhe Yang0Bei-Bei Zhang1Jian-Chun Huang2Xian-Yu Bai3Zhen-Qiang Liang4Xiang Yi5Ning Xu6Yuan-Jiao Huang7Ai-Jun Jiao8Graduate School of Guangxi Medical University, Nanning, ChinaInstitute of Biomedical Research, Yunnan University, Kunming, ChinaPharmaceutical College, Guangxi Medical University, Nanning, ChinaGraduate School of Guangxi Medical University, Nanning, ChinaDepartment of Otolaryngology-Head and Neck Surgery, Tumor Hospital of Guangxi Medical University, Nanning, ChinaDepartment of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, ChinaDepartment of Neurology, The First People’s Hospital of Nanning, Fifth Affiliated Hospital of Guangxi Medical University, Nanning, ChinaLife Science Institute, Guangxi Medical University, Nanning, ChinaPharmaceutical College, Guangxi Medical University, Nanning, ChinaNasopharyngeal carcinoma (NPC) is a malignant tumor in southern China, and nano Traditional Chinese Medicine (TCM) represents great potential to cancer therapy. To predict the potential targets and mechanism of polyphyllin II against NPC and explore its possibility for the future nano-pharmaceutics of Chinese medicine monomers, network pharmacology was included in the present study. Totally, ninety-four common potential targets for NPC and polyphyllin II were discovered. Gene Ontology (GO) function enrichment analysis showed that biological processes and functions mainly concentrated on apoptotic process, protein phosphorylation, cytosol, protein binding, and ATP binding. In addition, the anti-NPC effects of polyphyllin II mainly involved in the pathways related to cancer, especially in the PI3K-Akt signaling indicated by the Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. The “drug-target-disease” network diagram indicated that the key genes were SRC, MAPK1, MAPK14, and AKT1. Taken together, this study revealed the potential drug targets and underlying mechanisms of polyphyllin II against NPC through modern network pharmacology, which provided a certain theoretical basis for the future nano TCM research.http://dx.doi.org/10.1155/2021/9959634
spellingShingle Meng-Zhe Yang
Bei-Bei Zhang
Jian-Chun Huang
Xian-Yu Bai
Zhen-Qiang Liang
Xiang Yi
Ning Xu
Yuan-Jiao Huang
Ai-Jun Jiao
Network Pharmacology Reveals Polyphyllin II as One Hit of Nano Chinese Medicine Monomers against Nasopharyngeal Carcinoma
Bioinorganic Chemistry and Applications
title Network Pharmacology Reveals Polyphyllin II as One Hit of Nano Chinese Medicine Monomers against Nasopharyngeal Carcinoma
title_full Network Pharmacology Reveals Polyphyllin II as One Hit of Nano Chinese Medicine Monomers against Nasopharyngeal Carcinoma
title_fullStr Network Pharmacology Reveals Polyphyllin II as One Hit of Nano Chinese Medicine Monomers against Nasopharyngeal Carcinoma
title_full_unstemmed Network Pharmacology Reveals Polyphyllin II as One Hit of Nano Chinese Medicine Monomers against Nasopharyngeal Carcinoma
title_short Network Pharmacology Reveals Polyphyllin II as One Hit of Nano Chinese Medicine Monomers against Nasopharyngeal Carcinoma
title_sort network pharmacology reveals polyphyllin ii as one hit of nano chinese medicine monomers against nasopharyngeal carcinoma
url http://dx.doi.org/10.1155/2021/9959634
work_keys_str_mv AT mengzheyang networkpharmacologyrevealspolyphylliniiasonehitofnanochinesemedicinemonomersagainstnasopharyngealcarcinoma
AT beibeizhang networkpharmacologyrevealspolyphylliniiasonehitofnanochinesemedicinemonomersagainstnasopharyngealcarcinoma
AT jianchunhuang networkpharmacologyrevealspolyphylliniiasonehitofnanochinesemedicinemonomersagainstnasopharyngealcarcinoma
AT xianyubai networkpharmacologyrevealspolyphylliniiasonehitofnanochinesemedicinemonomersagainstnasopharyngealcarcinoma
AT zhenqiangliang networkpharmacologyrevealspolyphylliniiasonehitofnanochinesemedicinemonomersagainstnasopharyngealcarcinoma
AT xiangyi networkpharmacologyrevealspolyphylliniiasonehitofnanochinesemedicinemonomersagainstnasopharyngealcarcinoma
AT ningxu networkpharmacologyrevealspolyphylliniiasonehitofnanochinesemedicinemonomersagainstnasopharyngealcarcinoma
AT yuanjiaohuang networkpharmacologyrevealspolyphylliniiasonehitofnanochinesemedicinemonomersagainstnasopharyngealcarcinoma
AT aijunjiao networkpharmacologyrevealspolyphylliniiasonehitofnanochinesemedicinemonomersagainstnasopharyngealcarcinoma